Hollis-Eden Pharmaceuticals Company Profile

06:24 EDT 24th March 2018 | BioPortfolio

Hollis-Eden Pharmaceuticals is a development-stage pharmaceutical company, is engaged in the discovery, development and commercialization of products for the treatment of a number of targeted disease states caused byviral, bacterial, parasitic or fungal infections, including HIV/AIDS, hepatitis B and C, and malaria. The Company has three technology platforms, one based on cellular energy regulation, the second on a unique immune system modulation technology, and the third on biochemical synthesis regulators. The Company believes that certain of its drug candidates may provide the first long-term treatment for HIV without the development of viral strain resistance to the drugs' effectiveness, significant toxicity or severe side effects.


4435 Eastgate Mall
Suite, 400
San Diego
United States of America


Phone: (858)587-9333
Fax: (858)558-6470

News Articles [489 Associated News Articles listed on BioPortfolio]

MSU Athletic Director Mark Hollis Resigns In Wake Of Larry Nassar Scandal

Michigan State University athletic director Mark Hollis resigned Friday, two days after disgraced physician Larry Nassar was sentenced for seven counts of first-degree criminal sexual conduct, The As...

Eden Research sales jump as wine producers warm to natural pesticide

Eden uses terpenes produced by plants as the basis of its products

Eden Research PLC keen to add US to list of markets for natural fungicide

Sean Smith, chief executive of Eden Research PLC, explains the technology behind its range of naturally-derived pesticides and why winegrowers in France, Spain and Italy are giving rave reviews...

DDL Adds Photostability Testing to its Portfolio

Photostability testing of pharmaceuticals, combination products, cosmetics and other products now available at Eden Prairie, MN facility EDEN PRAIRIE, Minn. (PRWEB) November 15, 2017 DDL, Inc. announ...

Give the Gift of Healthy, Happy Hair for the Holidays with EDEN BodyWorks

Peppermint Tea Tree:Healthy hair starts with good scalp care. EDEN'S Peppermint Tea Tree Collection balances pH levels to stimulate the scalp and promote Read more...

Prenatal Exposure to Phthalates and the Development of Eczema Phenotypes in Male Children: Results from the EDEN Mother–Child Cohort Study

Introduction Phthalates are man-made chemicals widely used in our daily life [e.g., food wrappings, cosmetic products, children’s toys, cleaning products, medical devices, pharmaceuticals, polyv...

Toyota looks to adventure with its LA SUV concept

The Future Toyota Adventure Concept, or FT-AC, is a conceptual reminder to the car-buying public that SUVs can be driven off-road and can be used for adventure and exploration as well as the drive to ...

Dr. Andres R. Sanchez Offers Promotion for Receding Gums in Eden Prairie, MN

Dr. Andres R. Sanchez now offers a gum recession promotion, making the Pinhole® Surgical Technique more accessible to patients with receding gums and sensitive teeth in Eden Prairie, MN. EDEN PRA...

PubMed Articles [126 Associated PubMed Articles listed on BioPortfolio]

Paradise Lost Eden with Leish and Fer-de-Lance.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Clinical Trials [219 Associated Clinical Trials listed on BioPortfolio]

Clinical Study of Gene-Eden-VIR/Novirin

This study measured the changes in health-related complaints by analyzing charts of individuals, who are infected with a latent virus, who have used Gene-Eden-VIR/Novirin.

Latarjet Versus Modified Eden-Hybinnette for Anterior Shoulder Dislocation

Randomized clinical trial, parallel 1:1, comparing Latarjet to Modified Eden-Hybinnett (iliac bone crest + capsular repair) for recurrent traumatic anterior glenohumeral dislocation.

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1321 Associated Companies listed on BioPortfolio]

Hollis-Eden Pharmaceuticals, Inc.

Hollis-Eden Pharmaceuticals is a development-stage company with two product candidates in clinical trials: Apoptone® (HE3235), in the dose-escalation portion of a Phase I/II trial of patients with la...

Hollis-Eden Pharmaceuticals

Hollis-Eden Pharmaceuticals is a development-stage pharmaceutical company, is engaged in the discovery, development and commercialization of products for the treatment of a number of targeted disease ...

Next-Generation Pharmacist

Civic Leader of the Year: Peter Crouch, RPh, CCP, Eden Drug, Eden, N.C.

Eden Biodesign Ltd.

Eden Biodesign is a globally-integrated biopharmaceutical company offering consultancy, biopharmaceutical design, process development and cGMP manufacturing services to leading bi...

Eden Biodesign

Eden Biodesign is an integrated biopharmaceutical development organisation that evolved out of Eden Biopharm, a successful international development and manufacturing consultancy. Eden Biodesign is th...

More Information about "Hollis-Eden Pharmaceuticals" on BioPortfolio

We have published hundreds of Hollis-Eden Pharmaceuticals news stories on BioPortfolio along with dozens of Hollis-Eden Pharmaceuticals Clinical Trials and PubMed Articles about Hollis-Eden Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hollis-Eden Pharmaceuticals Companies in our database. You can also find out about relevant Hollis-Eden Pharmaceuticals Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Corporate Database Quicklinks

Searches Linking to this Company Record